In this op/ed column, the author describes findings from a pharmaceutical plant inspection using information from Redica Systems. Click here to access the article (article is behind a paywall).
Subscribe to Redica Insights
Get quality and compliance insights from our experts in your inbox
Or request a demo to talk with one of our team members.
Redica Systems Announces $30M Series B
Redica Systems Appoints New CTO to Accelerate Technological Innovation in the Next Stage of Growth
Redica Systems Announces Addition of Larry Coble as Chief Revenue Officer